ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy.

Cara A Rabik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.